Reply to the commentary on “The efficiency of pathological response after preoperative transcatheter arterial chemoembolization for microvascular invasion and early tumor recurrence in hepatocellular carcinoma”

We thank He et al.for their interest in our recent article(1)and for their thoughtful comments.The first question raised by He et al.is on the total number of patients in the PSM cohort in Table 1,which they considered incorrect.In this study,we first analyzed the incidences of MVI in the groups of patients with or without preoperative TACE.Before PSM,there were 737 patients who received preoperative TACE,and 1,233 patients who did not receive preoperative TACE.